Papers
Topics
Authors
Recent
Detailed Answer
Quick Answer
Concise responses based on abstracts only
Detailed Answer
Well-researched responses based on abstracts and relevant paper content.
Custom Instructions Pro
Preferences or requirements that you'd like Emergent Mind to consider when generating responses
Gemini 2.5 Flash
Gemini 2.5 Flash 45 tok/s
Gemini 2.5 Pro 54 tok/s Pro
GPT-5 Medium 22 tok/s Pro
GPT-5 High 20 tok/s Pro
GPT-4o 99 tok/s Pro
Kimi K2 183 tok/s Pro
GPT OSS 120B 467 tok/s Pro
Claude Sonnet 4 38 tok/s Pro
2000 character limit reached

Multi-Objective Molecule Generation using Interpretable Substructures (2002.03244v3)

Published 8 Feb 2020 in cs.LG and stat.ML

Abstract: Drug discovery aims to find novel compounds with specified chemical property profiles. In terms of generative modeling, the goal is to learn to sample molecules in the intersection of multiple property constraints. This task becomes increasingly challenging when there are many property constraints. We propose to offset this complexity by composing molecules from a vocabulary of substructures that we call molecular rationales. These rationales are identified from molecules as substructures that are likely responsible for each property of interest. We then learn to expand rationales into a full molecule using graph generative models. Our final generative model composes molecules as mixtures of multiple rationale completions, and this mixture is fine-tuned to preserve the properties of interest. We evaluate our model on various drug design tasks and demonstrate significant improvements over state-of-the-art baselines in terms of accuracy, diversity, and novelty of generated compounds.

Citations (22)

Summary

We haven't generated a summary for this paper yet.

List To Do Tasks Checklist Streamline Icon: https://streamlinehq.com

Collections

Sign up for free to add this paper to one or more collections.

Lightbulb On Streamline Icon: https://streamlinehq.com

Continue Learning

We haven't generated follow-up questions for this paper yet.